VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,458,661 | +82.8% | 165,688 | +104.5% | 0.05% | +75.0% |
| Q2 2023 | $2,438,976 | +251.3% | 81,002 | +277.5% | 0.03% | +211.1% |
| Q1 2023 | $694,237 | -84.4% | 21,460 | -88.1% | 0.01% | -92.5% |
| Q4 2022 | $4,442,747 | +301.0% | 180,188 | +292.1% | 0.12% | +566.7% |
| Q3 2022 | $1,108,000 | -13.0% | 45,957 | -1.2% | 0.02% | -14.3% |
| Q2 2022 | $1,274,000 | -71.1% | 46,517 | -59.6% | 0.02% | -70.4% |
| Q1 2022 | $4,414,000 | +352.3% | 115,063 | +277.7% | 0.07% | +373.3% |
| Q4 2021 | $976,000 | +45.9% | 30,467 | +34.2% | 0.02% | -11.8% |
| Q3 2021 | $669,000 | -44.2% | 22,708 | -35.6% | 0.02% | -46.9% |
| Q2 2021 | $1,198,000 | +28.8% | 35,258 | +23.2% | 0.03% | +14.3% |
| Q1 2021 | $930,000 | +34.2% | 28,613 | +48.7% | 0.03% | +21.7% |
| Q4 2020 | $693,000 | -87.3% | 19,238 | -86.2% | 0.02% | -87.9% |
| Q3 2020 | $5,460,000 | +13.5% | 139,413 | +6.3% | 0.19% | +1.1% |
| Q2 2020 | $4,812,000 | +1389.8% | 131,197 | +835.9% | 0.19% | +1075.0% |
| Q1 2020 | $323,000 | -9.0% | 14,019 | +15.4% | 0.02% | +14.3% |
| Q4 2019 | $355,000 | +19.1% | 12,149 | +9.2% | 0.01% | +7.7% |
| Q3 2019 | $298,000 | +24.7% | 11,130 | +19.0% | 0.01% | -13.3% |
| Q2 2019 | $239,000 | -5.9% | 9,351 | -17.6% | 0.02% | -6.2% |
| Q1 2019 | $254,000 | -6.6% | 11,351 | -11.9% | 0.02% | -11.1% |
| Q4 2018 | $272,000 | +5.8% | 12,884 | -7.0% | 0.02% | -10.0% |
| Q3 2018 | $257,000 | -16.0% | 13,851 | 0.0% | 0.02% | -28.6% |
| Q2 2018 | $306,000 | -1.6% | 13,851 | -1.0% | 0.03% | -22.2% |
| Q1 2018 | $311,000 | -8.3% | 13,995 | -3.3% | 0.04% | -21.7% |
| Q4 2017 | $339,000 | +3.0% | 14,473 | +4.3% | 0.05% | -9.8% |
| Q3 2017 | $329,000 | -99.9% | 13,878 | 0.0% | 0.05% | 0.0% |
| Q2 2017 | $298,516,000 | +87698.8% | 13,878 | -4.8% | 0.05% | -33.8% |
| Q1 2017 | $340,000 | -0.6% | 14,578 | -3.3% | 0.08% | -18.9% |
| Q4 2016 | $342,000 | -56.3% | 15,078 | -51.9% | 0.10% | -23.4% |
| Q3 2016 | $782,000 | – | 31,362 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |